PENTOSTATIN Drug Patent Profile
✉ Email this page to a colleague
When do Pentostatin patents expire, and what generic alternatives are available?
Pentostatin is a drug marketed by Rising and West-ward Pharms Int and is included in two NDAs.
The generic ingredient in PENTOSTATIN is pentostatin. There are two drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the pentostatin profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Pentostatin
A generic version of PENTOSTATIN was approved as pentostatin by WEST-WARD PHARMS INT on August 7th, 2007.
Summary for PENTOSTATIN
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 69 |
| Clinical Trials: | 62 |
| Patent Applications: | 259 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for PENTOSTATIN |
| DailyMed Link: | PENTOSTATIN at DailyMed |
Recent Clinical Trials for PENTOSTATIN
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Scripps Health | Phase 2 |
| City of Hope Medical Center | Phase 1 |
| California Institute for Regenerative Medicine (CIRM) | Phase 1 |
Medical Subject Heading (MeSH) Categories for PENTOSTATIN
Anatomical Therapeutic Chemical (ATC) Classes for PENTOSTATIN
US Patents and Regulatory Information for PENTOSTATIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rising | PENTOSTATIN | pentostatin | INJECTABLE;INJECTION | 203554-001 | Sep 19, 2014 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| West-ward Pharms Int | PENTOSTATIN | pentostatin | INJECTABLE;INJECTION | 077841-001 | Aug 7, 2007 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
